Get the Stockscreener App
2.69
2.54%
-0.07
Tela Bio Inc stock is traded at $2.69, with a volume of 28,831.
It is down -2.54% in the last 24 hours and down -4.95% over the past month.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
See More
Previous Close:
$2.76
Open:
$2.77
24h Volume:
28,831
Relative Volume:
0.16
Market Cap:
$108.71M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-1.6108
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
+1.89%
1M Performance:
-4.95%
6M Performance:
-32.92%
1Y Performance:
-60.84%
1-Day Range:
$2.66
$2.83
1-Week Range:
$2.56
$2.87
52-Week Range:
$2.30
$7.52
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
2.70 | 108.71M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.79 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.46 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.20 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.88 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
Tela Bio Inc Stock (TELA) Latest News
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research - MyChesCo
Annovis Bio Announces Public Offering of Common Stock and Warrants - MyChesCo
TELA Bio Inc to Host Earnings Call - ACCESS Newswire
TELA Bio Grants Inducement Stock Units to New Employees - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio Awards Equity Incentives to Seven New Strategic Hires - StockTitan
Jane Street Group LLC Sells 76,505 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by Geode Capital Management LLC - Defense World
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28% - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by State Street Corp - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3% – Here’s Why - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3%Should You Sell? - MarketBeat
TELA Bio Announces Inducement Grants for New Employees - MSN
TELA Bio's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
TELA Bio's SWOT analysis: stock poised for growth amid challenges - Investing.com
TELA Bio Awards Strategic Inducement Grants to Secure Key New Talent - StockTitan
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Yahoo Finance
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Nigeria
TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in November - MarketBeat
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
GSA Capital Partners LLP Purchases 89,712 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio to Present at Canaccord Genuity’s Growth Conference - MSN
TELA Bio Reports Strong Revenue Growth in Q3 2024 - MSN
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire
TELA Bio's SWOT analysis: innovative medical device stock faces growth hurdles - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Sees Large Decline in Short Interest - MarketBeat
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript - Insider Monkey
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely - Simply Wall St
TELA Bio stock target cut, keeps overweight rating on Q3 results - Investing.com Nigeria
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Tela Bio price target lowered to $5 from $8 at Piper Sandler - TipRanks
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings) - Benzinga
Piper Sandler Has Lowered Expectations for TELA Bio (NASDAQ:TELA) Stock Price - MarketBeat
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates - MSN
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance Australia
TELA Bio, Inc. Reports Record Revenue Growth - TipRanks
TELA Bio Inc Q3 2024 Earnings: Revenue Hits $19M, EPS at -$0.42, - GuruFocus.com
Tela Bio earnings missed by $0.02, revenue topped estimates - Investing.com UK
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tela Bio Inc Stock (TELA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '24 |
Sale |
4.74 |
378,000 |
1,791,720 |
2,457,542 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
1.29%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):